Long-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes

dc.contributor.authorDuru Cetinkaya, Pelin
dc.contributor.authorKayalar, Ozgecan
dc.contributor.authorEldem, Vahap
dc.contributor.authorArgun Baris, Serap
dc.contributor.authorKokturk, Nurdan
dc.contributor.authorKuralay, Selim Can
dc.contributor.authorBayram, Hasan
dc.date.accessioned2026-07-01T11:39:17Z
dc.date.available2026-07-01T11:39:17Z
dc.date.issued2025
dc.departmentDüzce Üniversitesi
dc.description.abstractThis study examined the long-term transcriptomic reprogramming in peripheral blood mononuclear cells (PBMCs) of severe COVID-19 patients and its effects for cancer development. RNA sequencing was conducted on PBMCs obtained from healthy controls, COVID-19 patients without pneumonia, and COVID-19 patients exhibiting severe pneumonia one year post-infection. Differential gene expression analysis identified a sustained pro-oncogenic molecular signature, especially among severe COVID-19 patients. Functional enrichment analysis revealed a substantial enrichment of cancer-associated pathways, encompassing apoptosis, viral carcinogenesis, and transcriptional dysregulation. Notably, the autophagy-related gene SQSTM1/P62 was recognized as a distinctive hub gene within the severe COVID-19 patients, interacting with pivotal genes associated with inflammation, apoptosis, and cancer advancement. Survival analysis demonstrated that elevated expression of COVID-19-associated hub genes correlated with unfavorable prognosis in various cancer types, including adrenocortical carcinoma, bladder urothelial carcinoma, and brain lower-grade glioma. These findings indicate that severe COVID-19 infection may establish a systemic milieu favorable to cancer development or recurrence, highlighting the necessity of prolonged oncological monitoring in these patients. Finding specific molecular targets and pathways can help us understand how COVID-19 might be linked to a higher risk of cancer.
dc.description.sponsorshipResearch Support Fund of the Turkish Thoracic Society [Y-2022-196] -- This research was funded by the Research Support Fund of the Turkish Thoracic Society (TTD). Grant number: Y-2022-196.
dc.identifier.doi10.3390/v17121608
dc.identifier.issn1999-4915
dc.identifier.issue12
dc.identifier.orcid0000-0001-7320-976X
dc.identifier.orcid0000-0003-4618-168X
dc.identifier.orcid0000-0001-8610-2937
dc.identifier.orcid0000-0002-4429-9441
dc.identifier.orcid0000-0001-7706-9311
dc.identifier.orcid0000-0001-9107-2381
dc.identifier.orcid0000-0002-9047-7608
dc.identifier.pmid41472277
dc.identifier.scopus2-s2.0-105026427445
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.3390/v17121608
dc.identifier.urihttps://hdl.handle.net/20.500.12684/23212
dc.identifier.volume17
dc.identifier.wosWOS:001647424900001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherMdpi
dc.relation.ispartofViruses-Basel
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20260623
dc.subjectCovid-19
dc.subjectTranscriptomics
dc.subjectPbmcs
dc.subjectLong-Term Effects
dc.subjectCancer Risk
dc.subjectDifferentially Expressed Genes
dc.subjectBioinformatics Analysis
dc.titleLong-Term Transcriptomic Reprogramming in Peripheral Blood Mononuclear Cells of Severe COVID-19 Survivors Reveals Pro-Oncogenic Signatures and Cancer-Associated Hub Genes
dc.typeArticle

Dosyalar